Aridis Pharmaceuticals, Inc. (ARDS)
OTCMKTS
· Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Mar 31, 2025
Aridis Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2015 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '23 Sep 30, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | 2015 - 2017 |
| Net Income | -1.14 | -30.37 | -42.19 | -22.33 | -29.68 | -22.11 | Upgrade
|
| Depreciation & Amortization | 0.31 | 0.49 | 0.44 | 0.34 | 0.34 | 0.28 | Upgrade
|
| Other Amortization | -0.25 | - | 0.25 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.19 | 0.23 | - | - | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | 0.01 | 0.95 | 0.04 | Upgrade
|
| Stock-Based Compensation | 0.97 | 1.48 | 2.28 | 2.13 | 2.01 | 1.66 | Upgrade
|
| Other Operating Activities | 0.49 | 0.35 | 5.77 | - | - | -1.63 | Upgrade
|
| Change in Accounts Receivable | -0.42 | -1 | - | -0.14 | 1.66 | -1.66 | Upgrade
|
| Change in Accounts Payable | 1.18 | -2.93 | 2.65 | -0.08 | -0.47 | 1.3 | Upgrade
|
| Change in Unearned Revenue | -20.74 | -0.84 | 2.15 | - | 19.58 | -0.1 | Upgrade
|
| Change in Other Net Operating Assets | 1.53 | 3.47 | 5.71 | -0.39 | -2.55 | -2.06 | Upgrade
|
| Operating Cash Flow | -17.89 | -29.13 | -22.94 | -20.48 | -8.16 | -24.27 | Upgrade
|
| Capital Expenditures | -0.05 | -0.08 | -0.53 | -0.37 | -0.17 | -0.68 | Upgrade
|
| Investment in Securities | - | - | - | - | - | -1 | Upgrade
|
| Investing Cash Flow | -0.04 | -0.08 | -0.53 | -0.37 | -0.17 | -1.68 | Upgrade
|
| Long-Term Debt Issued | - | 5 | 5 | 0.72 | - | - | Upgrade
|
| Total Debt Issued | 2.5 | 5 | 5 | 0.72 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -1.8 | - | - | - | - | Upgrade
|
| Total Debt Repaid | -2.84 | -1.8 | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -0.34 | 3.2 | 5 | 0.72 | - | - | Upgrade
|
| Issuance of Common Stock | 16.41 | 12.61 | 29.72 | 7.96 | 4.99 | 25.09 | Upgrade
|
| Other Financing Activities | -0.75 | -1.03 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 15.32 | 14.78 | 34.72 | 8.68 | 4.99 | 25.09 | Upgrade
|
| Net Cash Flow | -2.6 | -14.43 | 11.25 | -12.17 | -3.34 | -0.86 | Upgrade
|
| Free Cash Flow | -17.93 | -29.21 | -23.47 | -20.84 | -8.33 | -24.95 | Upgrade
|
| Free Cash Flow Margin | -80.21% | -944.97% | -1528.73% | -2084.30% | -815.36% | -904.90% | Upgrade
|
| Free Cash Flow Per Share | -0.56 | -1.56 | -1.91 | -2.27 | -0.98 | -7.93 | Upgrade
|
| Cash Income Tax Paid | 0.02 | 0.02 | 0 | 0 | 0 | 0 | Upgrade
|
| Levered Free Cash Flow | -16.39 | -17.85 | -15.53 | -8.82 | -2.8 | -15.55 | Upgrade
|
| Unlevered Free Cash Flow | -16.14 | -17.77 | -15.62 | -8.82 | -2.8 | -15.55 | Upgrade
|
| Change in Net Working Capital | 16.96 | 1.05 | -8.88 | -3.09 | -13.2 | 1.74 | Upgrade
|
Updated Nov 6, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.